共 16 条
[1]
Montastruc JL, Llau ME, Rascol O, Senard JM, Druginduced parkinsonism: a review, Fund Clin Pharmacol, 8, pp. 293-306, (1994)
[2]
Llau ME, Nguyen L, Senard JM, Rascol O, Montasruc JL, Syndromes parkinsoniens d'origine médicamenteuse: expérience d'un centre régional de pharmacovigilance sur dix ans, Rev Neurol (Paris), 150, pp. 757-762, (1994)
[3]
Brod TM, Fluoxetine and extrapyramidal side effects, Am J Psychiatry, 146, (1989)
[4]
Bouchard RH, Pourcher E, Vincent P, Fluoxetine and extrapyramidal side effects, Am J Psychiatry, 146, pp. 1352-1353, (1989)
[5]
Meltzer HJ, Young M, Metz J, Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant, J Neural Transm, 45, pp. 165-175, (1979)
[6]
Tate JL, Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine, Am J Psychiatry, 146, pp. 399-400, (1989)
[7]
Austin LS, Arana GW, Melvin JA, Toxicity resulting from lithium augmentation of antidepressant treatment in elderly patients, J Clin Psychiatry, 51, pp. 344-345, (1990)
[8]
Daric C, Dollfus S, Mihout B, Omnient Y, Petit M, Fluoxetine et syndromes extrapyramidaus. A propos de deux observations, Encephale, 19, pp. 61-62, (1993)
[9]
Chouinard G, Sultan S, A case of Parkinson's disease exacerbated by fluoxetine, Hum Psychopharmacol, 7, pp. 63-66, (1992)
[10]
Jansen, Increase of Parkinson disability after fluoxetine medication, Neurology, 43, pp. 211-213, (1993)